AHA, nursing home and long-term care group urge White House to follow up on staffing agency pricing concerns

Jan 27, 2022 - 03:12 PM
White House image

Many staffing agencies have been exploiting the severe shortage of health care personnel during the COVID-19 pandemic by charging uniformly high prices in a manner that suggests widespread coordination and abuse of market position, the AHA and American Health Care Association/National Center for Assisted Living today told White House COVID-19 Response Team Coordinator Jeffrey Zients.

“The AHA and AHCA/NCAL have each urged the Federal Trade Commission to investigate this conduct as a violation of our antitrust or consumer protection laws but we have not yet received any response,” the letter notes. “We ask that you help ensure this matter gets the attention it merits from the federal government.”

Earlier this week, nearly 200 House members also urged the White House to investigate reports that nurse staffing agencies are taking advantage of the COVID-19 pandemic to increase their profits at the expense of patients and the hospitals that treat them. 
 

Related News Articles

Headline
Senate committee advances appropriations bill
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Headline
AHA’s 2026 Next Gen fellows announced
The AHA’s Next Generation Leaders Fellowship July 29 announced its 36 fellows for the class of 2026, who will each work with mentors to address a specific…
Headline
AHA, Epic collaborate toward improving maternal health outcomes 
The AHA July 24 announced it is collaborating with health care technology leader Epic to help hospitals adopt tools that support the early detection and…
Headline
White House releases AI action plan
The White House July 23 released an action plan with a series of more than 90 policy recommendations to expand the use of artificial intelligence. The plan…
Headline
CMS issues letters to states on oversight of Medicaid, CHIP eligibility and certain demonstration authorities
The Centers for Medicare & Medicaid Services July 17 issued two letters to states regarding policies on continuous eligibility and workforce initiatives.…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…